These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Phenytoin induced agranulocytosis: direct and T cell-mediated mechanisms]. Matsuzaki M, Tokioka T, Suga K, Sueoka E, Ono K, Sano M, Shimamoto Y, Yamaguchi M. Rinsho Ketsueki; 1990 Apr; 31(4):474-8. PubMed ID: 2381064 [Abstract] [Full Text] [Related]
3. Phenytoin induced severe agranulocytosis and hepatitis. Kakar A, Byotra SP. J Assoc Physicians India; 1999 Jun; 47(6):644. PubMed ID: 10999171 [No Abstract] [Full Text] [Related]
4. Severe phenytoin-induced bone marrow depression and agranulocytosis treated with human recombinant granulocyte-macrophage colony-stimulating factor. Case report. Rawanduzy A, Sarkis A, Rovit RL. J Neurosurg; 1993 Jul; 79(1):121-4. PubMed ID: 8315450 [Abstract] [Full Text] [Related]
5. Toxic epidermal necrolysis in a patient receiving concurrent phenytoin and whole brain and thoracic radiotherapy. Ahmed I, Biswas A, Krishnamurthy S, Julka PK. Saudi Med J; 2014 Nov; 35(11):1393-5. PubMed ID: 25399219 [Abstract] [Full Text] [Related]
6. 'Double whammy': An Unusual Co-occurrence of Idiosyncratic phenytoin-induced agranulocytosis and acute liver failure in a child. Agarwal N. Trop Doct; 2024 Apr; 54(2):195-196. PubMed ID: 38280373 [Abstract] [Full Text] [Related]
9. Significant drug interaction: phenytoin toxicity due to erlotinib. Grenader T, Gipps M, Shavit L, Gabizon A. Lung Cancer; 2007 Sep; 57(3):404-6. PubMed ID: 17383767 [Abstract] [Full Text] [Related]
10. Phenytoin-induced toxic cholestatic hepatitis in a patient with skin lesions: case report. Altuntaş Y, Oztürk B, Erdem L, Günes G, Karul S, Uçak S, Sengül A. South Med J; 2003 Feb; 96(2):201-3. PubMed ID: 12630649 [Abstract] [Full Text] [Related]
16. Unmasking of Metamizole-induced Liver Injury by Simult aneous Development of Characteristic Agranulocytosis. Lutz M, Grünewald I, Lenze F, Heinzow H, Ullerich H, Kabar I, Schmidt HH, Tepasse PR. Curr Drug Saf; 2023 Jun; 18(3):404-412. PubMed ID: 35670337 [Abstract] [Full Text] [Related]